Intercept Pharmaceuticals
Lori Richards is an accomplished Senior Regional Business Director at Intercept Pharmaceuticals, where notable achievements include being named to the Pinnacle Club in 2022. With previous roles at Depomed, Inc., as District Sales Manager and Sales Specialist, Lori led an award-winning district and demonstrated expertise in strategic planning, speaker and KOL development, and sales performance. Earlier experience includes positions at Zogenix, Inc. and Takeda, where high sales performance and management of large territories were consistently achieved. Lori began a successful career at GSK, excelling as an Executive Senior Professional Representative with multiple President's Club recognitions. Lori holds a Bachelor’s Degree in Biology/Biological Sciences from Drake University.
This person is not in any teams
This person is not in any offices
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.